Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies (Q56978031)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2011

Language	Label	Description	Also known as
English	Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies	scientific article published on 01 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

0 references

interstitial lung disease

1 reference

based on heuristic

inferred from title

arterial hypertension

1 reference

based on heuristic

inferred from title

pulmonary hypertension

1 reference

based on heuristic

inferred from title

Jérôme Le Pavec

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Laura K. Hummers

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Gérald Simonneau

9

object named as

Gérald Simonneau

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Stephen C. Mathai

4

object named as

Stephen C Mathai

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Noah Lechtzin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Ari Zaiman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Reda E Girgis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Paul M Hassoun

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

1 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Arthritis and Rheumatism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

63

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2456-2464

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Changes in causes of death in systemic sclerosis, 1972-2002

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Treatment of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Systemic sclerosis-associated pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary hypertension associated with chronic respiratory disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Updated clinical classification of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Interstitial lung disease in systemic sclerosis: a simple staging system

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Is pulmonary arterial hypertension really a late complication of systemic sclerosis?

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Predictors of end stage lung disease in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Cyclophosphamide versus placebo in scleroderma lung disease.

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Systemic sclerosis and bilateral lung transplantation: a single centre experience

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

1 reference

https://api.crossref.org/works/10.1002%2FART.30423

21 January 2018

Identifiers

10.1002/ART.30423

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21538327%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56978031&oldid=2131051760"